Current Progress and Perspective: Clinical Imaging of Islet Transplantation

Area of Science:

• Regenerative Medicine
• Endocrinology
• Medical Imaging

Background:

• Islet transplantation shows promise for treating type 1 diabetes.
• Current limitations in non-invasive imaging hinder the monitoring of transplanted islet grafts.
• Assessing graft function and viability is critical for treatment success.

Purpose of the Study:

• To review recent clinical studies on non-invasive imaging modalities for transplanted islet grafts.
• To discuss molecular probes for monitoring beta cell mass and graft status.
• To explore in vivo detection of endogenous beta cell mass for longitudinal assessment.

Main Methods:

• Review of clinical studies on imaging modalities (e.g., MRI, PET, ultrasound).
• Analysis of molecular probes targeting beta cells.
• Discussion of techniques for in vivo imaging of beta cell mass.

Main Results:

• Various imaging modalities and molecular probes show potential for non-invasive monitoring.
• These methods can assess the functional status and viability of islet grafts.
• In vivo detection of endogenous beta cells aids in longitudinal monitoring.

Conclusions:

• Non-invasive imaging is essential for advancing islet transplantation therapy.
• Multimodality and novel imaging approaches offer future directions.
• Improved monitoring will enhance treatment outcomes for type 1 diabetes patients.